Abstract
The objective of this study was to determine the characteristics of cerebrovascular accidents at time of diagnosis in patients with giant cell arteritis. Retrospective data were collected from 98 patients at a single hospital with giant cell arteritis (according to the American College of Rheumatology classification criteria) diagnosed between October 1999 and January 2012. Cerebrovascular accident was found at initial presentation in 6 patients (6.1 %, 95 % CIs 2.3–12.9). Most of them had other symptoms of giant cell arteritis when the disease began. Signs reflecting the involvement of vertebro-basilar territory were present in 3 cases. No other case of cerebrovascular accident was described during the follow-up of patient; particularly no case of cerebrovascular accident occurred once corticosteroid therapy for the treatment of giant cell arteritis had been initiated. No differences in the epidemiologic, clinical and laboratory features at the time of diagnosis between patients who had cerebrovascular accidents and the rest of the giant cell arteritis patients were observed. Prognosis was good in our survey. However, there was no case of bilateral vertebral artery occlusion, a condition associated with poor prognosis. The present study confirms that cerebrovascular accidents may be the initial manifestation of giant cell arteritis, an argument in favor of a direct effect of the vasculitis in the development of cerebrovascular accidents rather than a complication of the corticosteroid therapy. The diagnosis of giant cell arteritis should always be considered in an elderly patient with stroke and an unexplained elevation of inflammatory biomarkers.
Similar content being viewed by others
References
Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2:261–271
Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139:505–515
Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Torres M (2008) Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis. Report of 7 cases and review of the literature. Medicine 87:335–344
Gonzales-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Dias MJ, Vazquez-Trinanes MC et al (2009) Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant-cell arteritis. Medicine 88:227–235
Gonzales-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497–1504
Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzales-Gay MA (2004) Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol 22(Suppl 36):S13–S17
Hunder CG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128
Caselli RJ, Hunder GG, Whisnant JP (1988) Neurologic disease in biopsy-proven giant-cell (temporal) arteritis. Neurology 38:352–359
Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50:1332–1337
Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteritis as a cause of first ever-stroke. Cerebrovasc Dis 24:226–230
Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G et al (2009) Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 48:250–253
Fitzgerald AJ, Ironside JW, Summers DM, Dennis MS, McRorie ER (2010) Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas. J Clin Rheumatol 16:225–228
Collazos J, Garcia-Monco C, Martin A, Rodriguez J, Angeles Gomez M (1994) Multiple strokes after initiation of steroid therapy in giant cell arteritis. Postgrad Med J 70:228–230
Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C (2009) High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) 48:258–261
Howard GF III, Ho SU, Kim KS, Wallach J (1984) Bilateral carotid artery occlusion resulting from giant-cell arteritis. Ann Neurol 15:204–207
Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55:985–989
Kumar A, Costa DD (2007) Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis. Age Aging 36:695–697
Ronthal M, Gonzales RG, Smith RN, Frosh MP (2003) Case records of the Massachusetts General Hospital. Case 21–2003. A 72-year-old man with repetitive strokes in the posterior circulation. N Engl J Med 349:170–180
Sheehan MM, Keohane C, Twomey C (1993) Fatal vertebral giant cell arteritis. J Clin Pathol 46:1129–1131
Richard S, Anxionnat R, Delaunay C, Ducrocq X (2009) Giant cell arteritis revealed by vertebrobasilar insufficiency. J Rheumatol 36:457–458
Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A et al (2004) Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 83:342–347
Cid MC, Font C, Oristrell J et al (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41:26–32
Ruegg S, Engelter S, Jeanneret C et al (2003) Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine 82:1–12
Boettinger MR, Sebastian SR, Gamulescu MAR, Grauer O, Ritzka M, Schuierer GR et al (2009) Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis. BMJ Case Rep. doi:10.1136/BCE.07.2008.0488
Ahdad R, Thabuy F, Menager de Froberville E, Brugieres P, Hosseini H (2008) Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis. Eur Neurol 59:331
Takekawa H, Daimon Y, Takashima R, Aiba S, Tanaka H, Hirata K (2008) Giant cell arteritis associated with lesion of the internal carotid artery: assessment of response to steroid therapy by magnetic resonance angiography. Intern Med 47:1285–1286
Lee MS, Smith SD, Galor A, Hoffman G (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309
Garcia–Garcia J, Ayo-Martin O, Argandona-Palacios L, Segura T (2011) Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis. Stroke 42:3287–3290
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zenone, T., Puget, M. Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis. Rheumatol Int 33, 3017–3023 (2013). https://doi.org/10.1007/s00296-013-2814-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2814-0